| Literature DB >> 35590306 |
Haihua Zhou1, Shian Yu2, Xiaokang Wu1, Xuemin Li1.
Abstract
BACKGROUND: To investigate the feasibility of purse string suture pancreaticojejunostomy in complete laparoscopic pancreaticoduodenectomy for patients with an undilated pancreatic duct.Entities:
Keywords: Laparoscopy; Pancreatic fistula; Pancreaticoduodenectomy; Pancreaticojejunostomy; Undilated pancreatic duct
Mesh:
Year: 2022 PMID: 35590306 PMCID: PMC9118586 DOI: 10.1186/s12893-022-01640-w
Source DB: PubMed Journal: BMC Surg ISSN: 1471-2482 Impact factor: 2.102
Fig. 1Flowchart of patient allocation
Patients demographics and clinical findings
| N = 113 | |
|---|---|
| Age (years) | 61 ± 10 (27–80) |
| Female/male (n) | 64/49 |
| Body mass index (kg/m2) | 22.73 ± 2.34 (17–28) |
| Preoperative total bilirubin of blood (μmol/L) | 98.32 ± 89.67 (8.6–352) |
| Preoperative blood albumin (g/L) | 38.05 ± 4.23 (30–48.7) |
| Preoperative biliary drainage (n) | |
| PTCD | 4 |
| PTGD | 2 |
| ENBD | 4 |
PTCD percutaneous transhepatic cholangial drainage, PTGD percutaneous transhepatic gallbladder drainage, ENBD endoscopic nasobiliary drainage
Fig. 2a An appropriate length of stenting tube was inserted into the main pancreatic duct. b The pancreatic stump was sutured with a 4-0 absorbable suture around the pancreatic duct, about 3 mm away from it, into a purse suture and the stent in the pancreatic duct was fixed with knot. c The posterior side of the pancreatic stump and the jejunal sarcomuscular layer were sutured with 3-0 Prolene suture. d Running pouch suture throughout the full thickness of intestinal wall surrounded the stent, about 3 mm from the jejunal incision, and tying the knot tightly. e Suture the anterior side of pancreatic stump and jejunum sarcomuscular layer with prolene thread
Patients demographics and clinical findings
| N = 113 | |
|---|---|
| Operative time (min) | 353 ± 41 (280–470) |
| Duration of PJ (min) | 27 ± 5 (20–40) |
| Diameter of Wirsung duct (n) | |
| ≤ 3 mm | 113 |
| Texture pancreas (hard/soft) (n) | 64/49 |
| Blood loss (mL) | 276 ± 213 (100–1000) |
| Postoperative hospital stay (days) | 16 ± 8 (7–70) |
| Histologic diagnosis (n) | |
| Pancreatice adenocarcinoma | 26 |
| Duodenal adenocarcinoma | 28 |
| Ampullary cancer | 29 |
| Bile duct cancer | 27 |
| Chronic pancreatitis | 1 |
| IPMN | 1 |
| Neuroendocrine carcinoma | 1 |
| Amylase level on drain fluid (IU/mL) (normal range 20–130) | |
| POD 1 | 42.34 ± 33.99 |
| POD 3 | 118.06 ± 202.13 |
| POD 5 | 146.38 ± 301.65 |
| Perianastomotic drain output (mL) | |
| POD 3 | 131 ± 79 |
| POD 5 | 141 ± 74 |
| Days of drain tube placement (days) | 13 ± 9 (7–63) |
| POPF, n (%) | |
| Biochemical leakage (BL) | 10 (8.85%) |
| B grade | 11 (9.73%) |
| C grade | 1 (0.88%) |
| Abdominal bleeding (n) | 1 |
| Gastroparesis (n) | 1 |
| Bile leakage (n) | 1 |
| Re-operation (n) | 2 |
| Mortality (n) | 0 |